SAVA: Total Utang marang Modal Cassava Sciences
The critical threshold of regulatory disputes and doubts regarding trial accuracy make operational risks extreme, allowing the price action of Cassava Sciences, Inc. (SAVA) available on the GURU.Markets chart to be used for monitoring the situation. The business relies on the development of an Alzheimer's disease therapy, mitigating risks through multi-stage testing. Meanwhile, management vigorously defends the authority of its research in court, and the indicator stands at 0.00.
%20-%20Utang%20marang%20Modal&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_SAVA_-_Cassava-Sciences-Inc._-_Debt-to-Capital "Rasio Total Utang marang Ekuitas: Cassava Sciences, Inc. (SAVA) kanggo 04.07.2022 - 11.03.2026 | 👁️GURU.Markets👁️")
Rincian metrik lan analitis perusahaan Cassava Pharma (SAVA)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator kapitalisasi buku:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas Cassava Sciences, Inc.|SAVA - Kewajiban jangka dawa marang modal|Utang jangka cendhak marang modal Cassava Sciences, Inc.|SAVA - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Cassava Sciences|SAVA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Cassava Sciences|Likuiditas cepet cassavasciences.com
- statistik bathi lan rasio pasar:
Analisis komprehensif perusahaan:Cassava Sciences, SAVA
This ratio determines the proportion of debt capital relative to equity, measuring the degree of financial leverage and the issuer's overall solvency. Analyzing the current debt-to-equity ratio is critically important for Cassava Sciences, Inc. (SAVA), as geopolitical instability restricts global drug trials, forcing the company to rely on the US domestic market and strictly control its debt sustainability.
Pesaing utama
Utang marang Ekuitas Biogen|Rasio Utang marang Ekuitas NBIX (Neurocrine)|Total Utang marang Modal RGC|AXSM - Utang marang Modal|ACADIA Pharmaceuticals - Rasio Total Utang marang Ekuitas|Total Utang marang Modal xenon-pharma.com XENE|VKTX - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SUPN (Supernus Pharmaceuticals, Inc.)|Catalyst Pharmaceuticals Inc (CPRX) - Utang marang Ekuitas|Utang marang Modal Denali Corp (DNLI)|HRMY (Harmony Biosciences) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas biohavenpharma.com (BHVN)|Total Utang marang Modal AMLX|Total Utang marang Modal Trevi Therapeutics Inc (TRVI)|Utang marang Ekuitas Praxis Medicines PRAX|Koefisien Total Utang marang Modal Anavex Life Sciences Corp (AVXL)|CBLL - Utang marang Ekuitas|Koefisien Total Utang marang Modal Prothena Corporation PLC PRTA|ALEC: Total Utang marang Modal|Annexon Biosciences (ANNX) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas OMER|Utang marang Ekuitas NGNE|Total Utang marang Modal ACIU|Total Utang marang Modal voyagertherapeutics.com (VYGR)|Neumora Therapeutics, Inc. - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SCLX|TVGN - Utang marang Ekuitas|Koefisien Total Utang marang Modal Alpha Cognition ACOG|CGTX: Total Utang marang Modal|Rasio Total Utang marang Ekuitas inhibikase.com|ASRT (Assertio Holdings) - Total Utang marang Modal|Coya (COYA) - Koefisien Total Utang marang Modal|Total Utang marang Modal VTGN|OVID - Utang marang Modal|Utang marang Ekuitas Acumen Pharmaceuticals ABOS|CRVO: Rasio Utang marang Ekuitas|Alterity Therapeutics Ltd - Total Utang marang Modal|Clene Inc. (CLNN) - Rasio Total Utang marang Ekuitas|PEPG: Total Utang marang Modal|Utang marang Modal Jupiter Neurosciences, Inc. (JUNS)|Utang marang Ekuitas Relmada Therapeutics|annovisbio.com (ANVS) - Koefisien Total Utang marang Modal|Rasio Total Utang marang Ekuitas GRCE (Grace Therapeutics, Inc.)|AIFF (Firefly Neuroscience, Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal KLTO (Klotho Neurosciences)|Koefisien Total Utang marang Modal NeuroSense Therapeutics Ltd (NRSN)|RVPH - Utang marang Ekuitas|MTVA (MetaVia Inc) - Rasio Utang marang Ekuitas|NRXS: Total Utang marang Modal|Rasio Total Utang marang Ekuitas Helius Medical Technologies|Rasio Total Utang marang Ekuitas PASG|Neuphoria (NEUP) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Minerva Neurosciences (NERV)|Koefisien Total Utang marang Modal athira.com|Total Utang marang Modal ADXN (Addex Therapeutics Ltd)|Total Utang marang Modal Alzamend Neuro Inc. ALZN|CYCN: Rasio Total Utang marang Ekuitas|PTIX: Utang marang Ekuitas|KTTA: Total Utang marang Modal|Cortigent (CRGT) - Total Utang marang Modal|Utang marang Ekuitas Avenue Therapeutics, Inc.|Rasio Utang marang Ekuitas BCLI (Brainstorm Cell Therapeutics Inc.)|Total Utang marang Modal CARA|CHRO - Utang marang Modal|Eliem Therapeutics Inc. - Rasio Total Utang marang Ekuitas|Total Utang marang Modal Intra-Cellular Therapies Inc. ITCI|LBPH - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi MRNS (Marinus Pharmaceuticals Inc)|NKGen (NKGN) - Utang marang Ekuitas|Utang marang Modal NeuroBo Pharma (NRBO)|SAGE (Sage Therapeutics, Inc.) - Total Utang marang Modal|Rasio Total Utang marang Ekuitas synaptogen.com (SNPX)|Total Utang marang Modal TRVN|Total Utang marang Modal vigilneuro.com (VIGL)|Utang marang Ekuitas Anew Medical WENA|Koefisien Total Utang marang Modal Cerevel Corp (CERE)